Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125477591 | 12547759 | 1 | I | 20160705 | 20160712 | 20160712 | EXP | CN-ROCHE-1792583 | ROCHE | LIU J, WANG J-H, LIU C-C AND YANG S-R. INDIVIDUALIZED TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH RECOMBINANT HUMAN ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY. UNKNOWN ;:-. | 30.00 | MON | M | Y | 14.00000 | KG | 20160712 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125477591 | 12547759 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Unknown | 125276 | 160 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125477591 | 12547759 | 1 | Juvenile idiopathic arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125477591 | 12547759 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125477591 | 12547759 | Pericardial effusion | |
| 125477591 | 12547759 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |